Le Lézard
Classified in: Health
Subject: PER

Body and Face Expert Dr. Michael Gartner Joins Exclusive Haute Beauty Network


Dr. Michael Gartner joins Haute Beauty Network as a body and face expert representing the New Jersey market.

NEW YORK, May 3, 2024 /PRNewswire-PRWeb/ -- Dr. Michael Gartner is fully certified as a plastic surgeon by the American Board of Plastic Surgery and is also fully certified as a general surgeon by the American Board of Surgery. As a Fellow of the American College of Surgeons, he is one of the few plastic surgeons in the country who have Double Board Certification. Dr. Gartner is world-renowned as an innovator in the field of aesthetic plastic surgery. He has refined his surgical techniques to provide a less invasive approach, so you won't have to deal with lengthy, overly uncomfortable recovery periods.

"He has refined his surgical techniques to provide a less invasive approach, so you won't have to deal with lengthy, overly uncomfortable recovery periods."

Dr. Gartner received his medical degree from the University of Medicine and Dentistry of New Jersey. He completed a one-year rotating internship at Atlantic Medical Center, where he was the Chief Intern, followed by a five-year General Surgery residency at Monmouth Medical Center in Long Branch, New Jersey, during which he was the Chief Resident in his final year. After an initial interest in cardiothoracic surgery, Dr. Gartner pursued plastic surgery instead not only because of the diversity in surgical procedures but also because it appealed to his artistic and creative sensibilities. To complement his training, he also trained for an additional year in Hand and Microsurgery at the world-renowned Thomas Jefferson University Hospital in Philadelphia.

Dr. Gartner has been repeatedly selected by the Consumer's Research Council of America as a top plastic surgeon in the country, as listed in Guide to America's Top Plastic Surgeons, editions dating from 2004-2013, as well as NJ Top Docs from 2013 to 2015. He is a member of the American Society of Plastic Surgeons, International Society of Aesthetic Plastic Surgery, New York Regional Society of Plastic and Reconstructive Surgeons, American College of Surgeons, American College of Surgeons New Jersey Chapter, American Medical Association, Cambridge Who's Who and Strathmore's Who's Who. Dr. Gartner has hospital affiliations with the Valley Hospital (Ridgewood, NJ), Paramus Surgery Center (Paramus, NJ), and Tri-State Surgery Center.

Learn more about Dr. Michael Gartner by visiting: https://hauteliving.com/hautebeauty/member/dr-michael-gartner/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living


These press releases may also interest you

at 04:45
ERS Genomics Limited (?ERS'), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS' CRISPR/Cas9 patent portfolio....

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: